Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 30 October 2026.
Announcements
660
Total raised
£938M
disclosed amounts
This month
£15.9M
raised so far
The Manchester startup raised the capital from early investors and advisors to expand its 3D digital twin platform for e-commerce.
"All of this starts from capturing a 3D digital twin with a short video. Our belief is simple: better product content builds buyer confidence – and buyer confidence drives conversion in ecommerce,"
The London-based AI start-up exceeded its target in an oversubscribed round backed by angel syndicates and customer-investors.
"Community has always been at the heart of LaunchLemonade. During this pre-seed cycle, that community compounded trust and carried our story and helped us show what LaunchLemonade can offer in the AI space."
The pre-seed funding will be used to scale the platform and expand solution offerings.
"We’re so pleased to have the backing of mission-aligned investors that really believe in our team and our plan. The commercial case for swapping unsustainable items and processes for a better way of doing things grows stronger every day, and we’re well-placed to help organisations act fast."
The company has also appointed James Hardy as an investor and strategic advisor.
"What really stood out to me was the strength of the team and the clarity of the model. incentifi is built around improving healthier lives while delivering a clear return for employers and partners. Having seen first-hand at Bioniq how impactful it can be when wellbeing and business objectives truly align, incentifi delivers exactly that. I’m excited to be part of the journey ahead."
The pre-series A round was backed by The FSE Group through the South West Investment Fund.
"Difficulty taking tablets is a common problem in paediatrics but extends to adults experiencing swallow impairment, including those suffering from serious conditions such as stroke, dementia and some forms of cancer. Our liquid products are effective and stable at room temperature with a long shelf life, improving medication adherence, dosage accuracy and convenience for the NHS, patients, and caregivers. We are thrilled to receive this investment, which will help us make a significant impact on the global pharmaceutical landscape."